Search
for
Sort by
Research 451–480 of 1000+
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- 83 Transcriptomic meta-analysis and deconvolution approaches unveil cellular dynamics in scarring and non-scarring primary lymphocytic alopecias
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Análise comparativa entre os tratamentos para alopecia: uma revisão sistemática
- A rare coexistence of alopecia areata and lichen planus
- Patients with Compound Heterozygous Mutations in Forkhead Box N1 have a Severe Immunodeficiency while Maintaining Normal Skin and Hair Development
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Increased proliferation of epidermal gamma delta T cells and expression of the transmembrane protein, BST2, in Alopecia areata
- The Role of Vitamin D and Testosterone Levels with Hair Loss among Females with Coronavirus Disease
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- The microbiome in patients with atopic dermatitis
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- DKK1 Mediated Inhibition of Wnt Signaling in Postnatal Mice Leads to Loss of TEC Progenitors and Thymic Degeneration
- The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination
- Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Medium-dose prednisolone pulse therapy in alopecia areata
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Under Development JAK Inhibitors for Dermatologic Diseases
- Emerging Unconventional Therapies for Alopecia Areata
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants